Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pediatric
Pharma
AZ touts Ultomiris results in post-transplant complication trial
Now that Ultomiris has matched the indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for the C5 drug to make its mark.
Fraiser Kansteiner
Jun 16, 2025 10:32am
AZ’s Alexion creates interactive storybook for kids with aHUS
Feb 12, 2025 12:00pm
Fierce 50: Breakthroughs honorees
Oct 2, 2023 4:00am
Sanofi and AZ snag US nod for RSV drug Beyfortus
Jul 17, 2023 2:31pm
MIT, Brigham push oral, oil-based delivery gel toward clinic
May 31, 2022 9:00am
Dupixent data in young eczema patients headed to regulators
Dec 13, 2021 2:19pm
